M. Murgia

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients.

S. Jordan, B. Kahan, M. Murgia, 1996, Kidney international.

Internal Jugular Vein Thrombosis after Positioning CVC in Dialysis Patients: The Most Common Ultrasound Patterns

A. Barracca, O. Manca, G. Pili, 2002, The journal of vascular access.

Parvovirus B19 infection inducing pure red cells medullary aplasia in kidney transplants patient

A. Pani, G. Piredda, M. Badiali, 2012 .

Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes.

C. Carcassi, A. Pani, G. Piredda, 2013, Journal of nephrology.

[Temporary vascular access for haemodialysis: is infection still the most important complication?].

A. Barracca, O. Manca, G. Pili, 2002, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

Potential Applications of Therapeutic Drug Monitoring of Sirolimus Immunosuppression in Clinical Renal Transplantation

J. Slaton, B. Kahan, K. Napoli, 1995, Therapeutic drug monitoring.

Three‐year health‐related quality‐of‐life outcomes for sirolimus‐treated kidney transplant patients after elimination of cyclosporine

G. Russ, D. Revicki, N. Jamieson, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Incidence of anemia in sirolimus‐treated renal transplant recipients: the importance of preserving renal function *

G. Russ, J. Chapman, P. Friend, 2007, Transplant international : official journal of the European Society for Organ Transplantation.